Tata Elxsi, a global leader in design and technology services, and Terumo Corporation, a global medical innovation company, today inaugurated the 'Terumo--Tata Elxsi Offshore Development Center'. This ...

Tata Elxsi has launched a global offshore development center for Terumo Corporation to support the development of cardiac and ...

Tata Elxsi has launched a global offshore development centre (ODC) for Terumo Corporation in Tokyo, aimed at enhancing the development of AI-driven cardiac and vascular solutions.

Tata Elxsi launched a global offshore development centre for Tokyo-based Terumo Corporation to enhance cardiac and vascular solutions using AI and GenAI. Shares of Tata Elxsi ended lower on Thursday, ...

SINGAPORE, March 5, 2026 /PRNewswire/ -- Terumo Blood and Cell Technologies (Terumo BCT) today announced the launch of its new C&GT Ecosystem Blueprint — a practical, collaborative approach designed ...

Terumo (TSE:4543) has recently announced a strategic outsourcing partnership with NAMSA to expedite the regulatory approval and commercialization of its products, reinforcing its competitive position ...

Terumo's Spectra Optia® Apheresis System Terumo's Spectra Optia® Apheresis System LAKEWOOD, Colo., U.S., and SANTA ROSA, Calif., U.S., July 27, 2022 (GLOBE NEWSWIRE) -- Acute kidney injury (AKI) and ...

Terumo Blood and Cell Technologies has entered a new collaboration with Taiwan Bio Therapeutics to transition regulatory T‑cell manufacturing onto the automated Quantum Flex platform, marking a shift ...

A jury in Jefferson County on Friday morning determined that Lakewood-based Terumo Blood and Cell Technology was not negligent in the release of the chemical ethylene oxide (EtO) into the community ...

Terumo, a medical device company based in Tokyo, Japan, will acquire Sequent Medical for $280 million, with up to $100 million more to be paid based on achievement of specific development objectives.